Tilray Brands, listed on the NASDAQ as TLRY, is a prominent player in the cannabis industry. The company is known for its production and distribution of medical and recreational cannabis products. As of December 2, 2025, TLRY underwent a reverse stock split at a ratio of 10 for 1, a strategic move to consolidate its shares and potentially stabilize its stock price.
The reverse stock split, approved by stockholders in June 2025, reduced the total number of outstanding shares from approximately 1.16 billion to 116 million. This adjustment aims to increase the stock price by consolidating every 10 shares into one. Despite this strategic move, Tilray's shares have experienced a significant decline, dropping over 20% during a recent trading session, contributing to a nearly 40% loss in 2025.
As highlighted by the recent trading activity, Tilray's stock price has fluctuated significantly. Currently priced at $8.64, the stock has seen a 10.49% increase with a change of $0.82. The trading volume for TLRY is 5.37 million shares, indicating active investor interest. However, the stock has experienced a wide range of fluctuations, with a low of $7.17 and a high of $8.95 in a single day. However, there is potential for further selling pressure, which could impact the stock's performance in the near term.
